Corrigendum to ‘Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia’ [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1–109]
Michael S. Conte(University of California San Francisco Medical Center), Peter Robless, Lawrence A. Lavery(The University of Texas at San Antonio), Manesh R. Patel(Duke University), Matthew T. Menard, Hans‐Henning Eckstein(TUM Klinikum), Andrew W. Bradbury(University of Birmingham), Nabil Chakfé, Joseph Dawson(Royal Adelaide Hospital), J. J. F. Belch(Ninewells Hospital), David G. Armstrong(Keck Hospital of USC), Florian Dick(Kantonsspital St. Gallen), Nobuyoshi Azuma(Asahikawa Medical University), Robert J. Hinchliffe(North Bristol NHS Trust), Kimihiro Komori(Saiseikai Yahata General Hospital), R. Lookstein, Patrick J. Geraghty, Murat Aksoy, M. Hassan Murad(Mayo Clinic), Vlad-Adrian Alexandrescu, Alberto Muñoz, Victor Aboyans(The Princess Grace Hospital), Andrew Dueck, Jose A. Munoa Prado, Sanjay Misra(Mayo Clinic), Mauro Garguilo(University of Bologna), Tetsuro Miyata(Sanno Medical Center), Jean‐Baptiste Ricco(Primary Health Care), Martin Björck(Uppsala University), Robert Fitridge(Royal Adelaide Hospital), Prem Chand Gupta, Bruce H. Gray, Roberto Ferraresi, Joseph L. Mills(Baylor College of Medicine), Steve Goode, Prasad Jetty(University of Ottawa), Wei Guo(Chinese PLA General Hospital), Wei Liang(Renji Hospital), Eike Sebastian Debus(Universität Hamburg), Richard J. Powell(Dartmouth College), Stephen W.K. Cheng(Queen Mary Hospital), Philippe Kolh, John V. White(Advocate Lutheran General Hospital), Raghvinder Pal Singh Gambhir, Frank B. Pomposelli(Boston University), Kalkunte R. Suresh, Juan E. Paolini, G.L. Moneta, Michel Bergoeing
Cited by 16
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k